Awareness Capital Management

Awareness Capital is a global venture capital firm investing in scalable, AI-enabled companies across brain and mental health. We focus where strong science, early traction, and disciplined execution meet—backing companies translating breakthrough research into diagnostics, therapeutics, and new models of care. Our strategy centers on “beyond startup” companies with validated models, combining scientific rigor with commercial judgment to support companies from early traction to global scale. Through a differentiated, ecosystem-driven platform spanning the U.S. and Europe, we bring together domain expertise, scientific networks, and pathways to adoption—aiming to improve access, affordability, and outcomes across brain and mental health care. ▪ What is Awareness Capital's investment thesis? Awareness Capital invests where strong science, early traction, and disciplined execution converge. The firm focuses on three areas: early detection technologies, including novel biomarkers and AI-powered diagnostics; treatment innovation spanning targeted therapeutics, digital therapeutics, and personalized approaches; and community infrastructure — the tools, services, and networks that make brain health support more practical and accessible. Capital follows evidence and conviction rather than category excitement. ▪ What stage companies does Awareness Capital invest in? Awareness Capital invests primarily in early to growth-stage companies. The portfolio spans Seed through Series B, with a focus on companies that have moved beyond pure research and have credible clinical or commercial traction. The firm evaluates opportunities based on scientific rigor, regulatory pathway clarity, and the operational capacity to translate innovation into real-world adoption.